Prescription Technology Solutions — Restructuring Charges
McKesson Prescription Technology Solutions — Restructuring Charges remained flat by 0.0% to $5M in Q4 2026 compared to the prior quarter. Year-over-year, this metric declined by 58.3%, from $12M to $5M. Over 4 years (FY 2022 to FY 2026), Prescription Technology Solutions — Restructuring Charges shows a downward trend with a -5.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High charges indicate aggressive transformation efforts, which may lead to future margin expansion if successful.
Detailed definition
Aggregates all costs associated with formal restructuring programs designed to improve the profitability and operational...
Peer comparison
Widely used metric across the industry to track the cost of corporate transformation and efficiency programs.
mck_segment_prescription_technology_solutions_restructuring_chargesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18M | $0 | $0 | $10M | $7M | $7M | $1M | $36M | $2M | $3M | $2M | $6M | $4M | $1M | $0 | $0 | $0 | $0 | $12M | $5M | $5M | $5M | $5M |
| QoQ Change | — | -100.0% | — | — | -30.0% | +0.0% | -85.7% | >999% | -94.4% | +50.0% | -33.3% | +200.0% | -33.3% | -75.0% | -100.0% | — | — | — | — | -58.3% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -61.1% | — | — | +260.0% | -71.4% | -57.1% | +100.0% | -83.3% | +100.0% | -66.7% | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | -58.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — restructuring charges?
- McKesson (MCK) reported prescription technology solutions — restructuring charges of $5M in Q4 2026.
- How has McKesson's prescription technology solutions — restructuring charges changed year-over-year?
- McKesson's prescription technology solutions — restructuring charges decreased by 58.3% year-over-year, from $12M to $5M.
- What is the long-term trend for McKesson's prescription technology solutions — restructuring charges?
- Over 4 years (2022 to 2026), McKesson's prescription technology solutions — restructuring charges has grown at a -5.4% compound annual growth rate (CAGR), from $25M to $20M.
- What does prescription technology solutions — restructuring charges mean?
- Total expenses related to organizational restructuring programs within the technology solutions segment.